Company news
Biomerica, Inc. (NASDAQ:BMRA) news
Every Biomerica, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Biomerica Reports Fiscal 2026 Year-End Financial Results
September 1, 2026
Biomerica : Annual Report for Fiscal Year Ending May 31, 2026 (Form 10-K)
August 31, 2026
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
May 28, 2026
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
April 29, 2026
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods IBS, Opening a Scalable Medica...
April 17, 2026
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medic...
April 16, 2026
Biomerica Launches inFoods IBS in Canada through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs
April 15, 2026
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs
April 14, 2026
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
April 13, 2026
Biomerica Receives First Commercial Order for its H. pylori test from one of the Largest Clinical Laboratory Chains in Europe
March 19, 2026
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe
March 18, 2026
Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain
March 5, 2026
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Red...
February 26, 2026
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
February 18, 2026
Biomerica Reports Second Quarter Fiscal 2026 Financial Results
January 14, 2026
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
December 23, 2025
Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio
December 12, 2025
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
December 11, 2025
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach...
November 25, 2025
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand
November 6, 2025
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.
October 16, 2025
Biomerica Reports First Quarter Fiscal 2026 Financial Results
October 15, 2025
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors
October 8, 2025
Biomerica : Amendment to Annual Report (Form 10-K/A)
September 26, 2025
Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes
September 9, 2025
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use
September 3, 2025
Biomerica Reports Fiscal 2025 Year End Results
August 29, 2025
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use
August 14, 2025
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
July 2, 2025
Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer
June 26, 2025
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
June 6, 2025
Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
June 5, 2025
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient...
May 22, 2025
PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement
May 7, 2025
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection
April 23, 2025
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage
April 17, 2025
Biomerica Announces Reverse Stock Split
April 16, 2025
Biomerica Reports Third Quarter Fiscal 2025 Financial Results
April 15, 2025
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
February 26, 2025
Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal
February 19, 2025
Biomerica Reports Second Quarter Fiscal 2025 Financial Results
January 15, 2025
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
November 21, 2024
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain
October 30, 2024
Biomerica Reports First Quarter Fiscal 2025 Financial Results
October 16, 2024
Biomerica Reports Fiscal 2024 Year End Results
August 29, 2024
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers
July 1, 2024
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024
May 13, 2024
Biomerica Reports Third Quarter 2024 Financial Results
April 12, 2024
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
February 21, 2024
Biomerica Reports Second Quarter 2024 Financial Results
January 16, 2024